KATRINA POULSEN: Open Payments
NPI 1396342713 · ST. GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 25 payments from 9 companies in 2025. Trend: 2023 $341 · 2024 $504 · 2025 $528
Food & beverage: $448Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $208 |
| Janssen Biotech, Inc. | 4 | $138 |
| Biofrontera Inc. | 4 | $67 |
| Almirall LLC | 1 | $29 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| UCB, Inc. | 1 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
Products named: TREMFYA, SKYRIZI, BOTOX, Seysara, VALCHLOR, RINVOQ, AKLIEF, EBGLYSS.
Industry payments across UT — which companies pay providers there.
